Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares OutstandingShares Outstanding
Ratios

Medifast (MED) Leases (2019 - 2025)

Medifast's Leases history spans 7 years, with the latest figure at $7.2 million for Q4 2025.

  • For Q4 2025, Leases fell 35.17% year-over-year to $7.2 million; the TTM value through Dec 2025 reached $7.2 million, down 35.17%, while the annual FY2025 figure was $7.2 million, 35.17% down from the prior year.
  • Leases reached $7.2 million in Q4 2025 per MED's latest filing, down from $8.4 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $24.5 million in Q4 2021 to a low of $7.2 million in Q4 2025.
  • Average Leases over 5 years is $15.1 million, with a median of $15.7 million recorded in 2023.
  • Peak YoY movement for Leases: skyrocketed 138.41% in 2022, then crashed 35.17% in 2025.
  • A 5-year view of Leases shows it stood at $24.5 million in 2021, then fell by 24.52% to $18.5 million in 2022, then dropped by 15.25% to $15.6 million in 2023, then decreased by 28.7% to $11.2 million in 2024, then plummeted by 35.17% to $7.2 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Leases are $7.2 million (Q4 2025), $8.4 million (Q3 2025), and $8.9 million (Q2 2025).